Cancer Research
New biomarker improves early lung cancer detection
4. Oktober 2025 Bild generiert von KI
Researchers have identified a novel protein biomarker that detects lung cancer at an early stage with high accuracy. The discovery, detailed in a recent study, could enhance screening methods and improve patient outcomes. Clinical trials showed promising results in identifying the disease before symptoms appear.
DNA scar catalog opens paths to overcome cancer drug resistances
3. Oktober 2025 Von KI berichtet
Researchers at Spain's National Cancer Research Centre (CNIO) have developed a comprehensive catalog of mutational 'scars' in DNA caused by cancer. This breakthrough, published in Nature, could help bypass resistances to treatments like PARP inhibitors. The study analyzes thousands of tumor samples to identify key genetic patterns.
Researchers develop new method for early cancer detection
Scientists at the University of Cambridge have unveiled a groundbreaking blood test that detects cancer earlier than existing methods. The technique analyzes circulating tumor DNA with high accuracy. This innovation could revolutionize screening and treatment worldwide.
Summit's Lung Cancer Drug Shows Promise
Biotech company Summit announced promising results from its lung cancer drug in recent trials. The drug demonstrated potential efficacy in treating advanced cases, marking a step forward in oncology treatments. Further studies are planned to confirm these findings.
Scientists uncover cancer cells' mitochondrial energy surge under pressure
5. Oktober 2025 Von KI berichtet
Researchers have discovered that cancer cells respond to physical squeezing by rapidly deploying mitochondria to the nucleus, delivering a burst of ATP to repair DNA damage and ensure survival. This mechanism, observed in lab experiments and patient biopsies, could inspire new strategies to halt cancer spread. The finding redefines mitochondria's role as dynamic responders rather than static energy sources.